Save a Life. Make a Recommendation: Emerging Themes in Cancer Screening - Weight Stigma in Cancer Care: Strategies for Improvement
This activity aims to provide emerging cancer related information and resources specifically pertaining to breast and cervical cancer screening and prevention. Participants will gain an understanding of specific population health needs and emerging research in cancer screening and care.
Session Educational Need
Research shows that health care providers are biased toward overweight and obese individuals resulting in weight discrimination and disparities in care. Overweight and obese individuals are less likely than their “normal weight” peers to receive appropriate recommendations for preventative screening and are more likely to report negative experiences with health care providers. These issues lead to increased risks of developing mental health conditions, unhealthy eating behaviors, and avoidance of exercise.
Session Learning Objectives
- Recognize weight bias and how it manifests in clinical cancer care.
- Develop strategies for mitigating internalized weight bias.
- Discuss how weight loss is not always clinically indicated for patients with elevated BMI.
- Implement improved communication with patients with obesity using the 5As model.
Visit the links below to view the other sessions of the Save a Life. Make a Recommendation: Emerging Themes in Cancer Screening series.
May 18, 2022 - Cancer Care in the LGBTQ Community
May 25, 2022 - Hidden Dangers in the Mouth - How Dental Disease Impacts the Body
Sarah Nash, PhD, MPH, CPH
Assistant Professor, Epidemiology, University of Iowa
Dr. Nash’s research blends data science with community engagement to understand and address cancer health disparities, particularly among Indigenous and rural communities. Dr. Nash’s research portfolio can be considered under three broad themes: using publicly available data to describe of the burden of cancer and address cancer disparities; health services research to understand the provision of cancer prevention and treatment services, and the impact of care on cancer outcomes; and epidemiologic studies to understand risk and protective factors for cancer and other chronic diseases. Her research broadly utilizes a community-based participatory research framework, as well as mixed-methods approaches. View her CV.
Katie Robinson, MD, PhD, ABOM
Department of Internal Medicine, University of Iowa
- MD - University of Wisconsin
- PhD - University of Wisconsin
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and Iowa State University. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit will be awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No ineligible company provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Sarah Nash, PhD, MPH, CPH - Speaker
- Katie Robinson, MD, PhD, ABOM - Speaker
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 IBON